Research Summary
An Influenza Rapid Diagnostic Test (RIDT) is a diagnostic tool designed for the quick and on-the-spot detection of the influenza virus. These tests are commonly used in healthcare settings, allowing for rapid results and timely decision-making in the management of influenza cases. RIDTs work by detecting specific viral antigens present in respiratory specimens such as nasal swabs or throat swabs. The procedure usually involves combining the patient's specimen with antibodies that can bind to influenza virus antigens. If the virus is present, a visible reaction occurs, indicating a positive result. Influenza RIDTs are valued for their speed and simplicity, providing results within minutes, which is especially beneficial for prompt clinical decision-making during flu seasons or outbreaks. While RIDTs are convenient for quick screening, more comprehensive diagnostic methods like molecular testing may be employed for confirmation and in cases where higher sensitivity and specificity are required.
According to DIResearch's in-depth investigation and research, the global Influenza Rapid Diagnostic Test market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Influenza Rapid Diagnostic Test include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Rapid Diagnostic Test. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Influenza Rapid Diagnostic Test market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Influenza Rapid Diagnostic Test market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Rapid Diagnostic Test industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Influenza Rapid Diagnostic Test Include:
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Influenza Rapid Diagnostic Test Product Segment Include:
Digital RIDTs
Conventional RIDT
Influenza Rapid Diagnostic Test Product Application Include:
Hospitals
POCT
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Influenza Rapid Diagnostic Test Industry PESTEL Analysis
Chapter 3: Global Influenza Rapid Diagnostic Test Industry Porter’s Five Forces Analysis
Chapter 4: Global Influenza Rapid Diagnostic Test Major Regional Market Size and Forecast Analysis
Chapter 5: Global Influenza Rapid Diagnostic Test Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Influenza Rapid Diagnostic Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Influenza Rapid Diagnostic Test Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook